- Q1 2024 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 08, 2024€1.06 (+3.41%)Earnings
- Q4 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 29, 2024€1.06 (-15.69%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 02, 2023€0.7496 (-6.25%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Karyopharm Therapeutics Inc at HC Wainwright Investment Conference - New York TranscriptSep 11, 2023
- Q2 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 02, 2023€1.51 (-7.77%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 04, 2023€2.62 (-18.49%)Earnings
- Karyopharm Therapeutics Inc to Host Investor Webcast on Selinexor Data in Patients with Treatment-Naive Myelofibrosis at AACR 2023 TranscriptApr 18, 2023
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 15, 2023€3.38 (+9.09%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Karyopharm Therapeutics Inc Investor and Analyst Event at ASH TranscriptDec 12, 2022
- Q3 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 03, 2022€4.59 (-0.69%)Earnings
- Karyopharm Therapeutics Inc at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2022
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 04, 2022€4.77 (+3.82%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Karyopharm Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Q1 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 05, 2022€5.9 (-0.10%)Earnings
- Karyopharm Therapeutics Inc at Canaccord Genuity Horizons in Oncology Conference (Virtual) TranscriptApr 14, 2022
- Karyopharm Therapeutics Inc SIENDO Study Results Call TranscriptMar 17, 2022
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Q4 2021 Karyopharm Therapeutics Inc Earnings, 2022 Financial Outlook and SIENDO Topline Results Discussion Call TranscriptFeb 08, 2022
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Karyopharm Therapeutics Inc Virtual Investor Day TranscriptDec 08, 2021
- Karyopharm Therapeutics Inc at Jefferies London Healthcare Conference (Virtual) - On-Demand TranscriptNov 18, 2021
- Q3 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 03, 2021€6.9 (+38.83%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Karyopharm Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) - Pre-Recorded TranscriptSep 13, 2021
- Q2 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 05, 2021€4.98 (-25.77%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- Karyopharm Therapeutics Inc Annual Shareholders Meeting TranscriptMay 21, 2021
- Q1 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 03, 2021€7.45 (-5.67%)Earnings
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 11, 2021€12.96 (-1.97%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Karyopharm Therapeutics Inc - Karyopharm XPOVIO® FDA Approval in Multiple Myeloma Conference Call TranscriptDec 18, 2020
- Karyopharm Therapeutics Inc - Investor And Analyst ASH Event (Virtual) TranscriptDec 08, 2020
- Karyopharm Therapeutics Inc - Phase 3 SEAL Top-Line Results Conference Call TranscriptNov 20, 2020
- Karyopharm Therapeutics Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 02, 2020€12.39 (-4.84%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Q2 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 04, 2020€13.49 (-2.95%)Earnings
- Karyopharm Therapeutics Inc to Discuss The FDA's Approval Of XPOVIO TranscriptJun 22, 2020
- Karyopharm Therapeutics Inc BOSTON Data Conference Call TranscriptMay 29, 2020
- Karyopharm Therapeutics Inc Annual Shareholders Meeting TranscriptMay 21, 2020
- Karyopharm Therapeutics Inc at RBC Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Q1 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 05, 2020€18.9 (+8.00%)Earnings
- Karyopharm Therapeutics Inc - Discuss Selinexor As A Potential Treatment For Hospitalized Patients With COVID-19 TranscriptApr 07, 2020
- Karyopharm Therapeutics Inc. Phase 3 BOSTON Study Top-line Results Conference Call TranscriptMar 02, 2020
- Q4 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 13, 2020€15.1 (-3.82%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q3 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 04, 2019€12.3 (+18.27%)Earnings
- Q2 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 06, 2019€6.87 (-5.63%)Earnings
- Karyopharm Therapeutics Inc Corporate Call TranscriptJul 03, 2019
- Karyopharm Therapeutics Inc at JMP Securities Life Science Conference TranscriptJun 19, 2019
- Q1 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 09, 2019€4.12 (-2.60%)Earnings
- Q4 2018 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 28, 2019€3.7 (-6.33%)Earnings
Karyopharm Therapeutics Inc Annual Shareholders Meeting Transcript
Ladies and gentlemen. Welcome to the Karyopharm Therapeutics Inc. meeting. Your speaker for today, Michael Kauffman, will now begin.
Good afternoon. I am Michael Kauffman, Chief Executive Officer and the Director of Karyopharm Therapeutics. I'd like to welcome you all to Karyopharm's 2020 Annual Meeting of Stockholders. We have chosen to hold our annual meeting this year as a virtual meeting in order to better support the health and well-being of our stockholders, employees and directors in light of the COVID-19 outbreak, and we welcome you to this live webcast. We have designed this meeting to provide stockholders the same rights and opportunities to participate as they would at an in-person meeting. It is now 2:00 p.m. Eastern time on this 21st day of May 2020, and I call this meeting to order.
I will be serving as Chairman of today's meeting, and I've asked Chris Primiano, our Executive Vice President, Chief Business Officer, General Counsel and Secretary, to act as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)